Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: a systematic review
- PDF / 1,232,966 Bytes
- 13 Pages / 595.276 x 790.866 pts Page_size
- 39 Downloads / 243 Views
Economic evaluation of the utilization of telemedicine for patients with cardiovascular disease: a systematic review Hiro Farabi 1 & Aziz Rezapour 2 & Reza Jahangiri 2 & Abdosaleh Jafari 3 & Asma Rashki Kemmak 2 & Shima Nikjoo 2
# Springer Science+Business Media, LLC, part of Springer Nature 2019
Abstract Cardiovascular disease is one of the major causes of mortality in the world, with high human and financial burdens on communities. Telemedicine is a tool for providing services for patients that are difficult to access or in need of immediate care. The aim of this study was to systematically review economic evaluation studies that compared telemedicine with usual care for cardiovascular patients. A systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and related articles published up to December 2018 were searched in different databases (PubMed, Embase, SCOPUS, Global Health, Google Scholar, Magiran, SID). The articles were selected based on inclusion and exclusion criteria. Consolidated health economic evaluation reporting standards statement checklist was used to qualitatively evaluate the papers. Overall, 20 articles were included in the study. The studies used quality-adjusted life years to measure outcomes. The highest and lowest values of Incremental Cost-effectiveness Ratio were $515,082 and $2099 that had been reported in the UK and New Zealand, respectively. Most of the items of the checklist were reported and the quality of most of the studies was excellent and very good. According to the results, telemedicine improves the clinical outcomes and results in considerable saving in costs. Utilizing telemedicine concurrent with the usual care for service delivery is more cost-effective. The reviewed studies had been conducted in high-income countries, hence, it is essential to be cautious when generalizing the results and applying them in health systems policymaking. Keywords Cardiovascular disease . Telemedicine . Economic evaluation . Cost-benefit analysis . Systematic review
Introduction Cardiovascular disease is the most common cause of morbidity, rehospitalization, and mortality in many countries of the world and is the leading cause of disability [1]. According to the reports by the World Health Organization, every year, more than 17.9 million people die from cardiovascular
* Aziz Rezapour [email protected] 1
Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
2
Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
3
Health Human Resources Research Centre, School of Management and Medical Information Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
disease, which accounts for about 31% of deaths occurring worldwide [2]. Half of the mortality and 80% of the global burden of cardiovascular disease are observed in low- and middle-i
Data Loading...
